Explain this page of first Aid according to my usmle step 1 exam with high yeild points and mcqs related to usmle

Reading File

Finding Sources

Here is a comprehensive, high-yield breakdown of First Aid page 609 — Nephron Transport Physiology — organized by segment, with USMLE-style MCQs at the end.

Nephron Transport Physiology — USMLE Step 1 High-Yield Breakdown

1. PROXIMAL CONVOLUTED TUBULE (PCT)

Key Facts

Reabsorbs 65–80% of Na⁺ and H₂O (isotonic absorption — osmolarity doesn't change)
Has a brush border (increases surface area)
Reabsorbs: all glucose, all amino acids, most HCO₃⁻, Na⁺, Cl⁻, PO₄³⁻, K⁺, H₂O, uric acid
Generates and secretes NH₃ → enables more H⁺ secretion
The Na⁺/K⁺-ATPase on the basolateral membrane drives all reabsorption

Drug/Hormone Targets

Agent	Action	Effect
SGLT-2 inhibitors (gliflozins)	Block Na⁺/glucose cotransporter	↓ glucose reabsorption → glycosuria
Acetazolamide	Inhibits carbonic anhydrase (CA)	↓ HCO₃⁻ reabsorption → metabolic acidosis
Angiotensin II	Stimulates Na⁺/H⁺ exchange	↑ Na⁺, H₂O, HCO₃⁻ reabsorption (contraction alkalosis)
PTH	Inhibits Na⁺/PO₄³⁻ cotransport	↑ PO₄³⁻ excretion in urine

Carbonic Anhydrase (PCT)

CO₂ + H₂O → H₂CO₃ → H⁺ + HCO₃⁻
H⁺ secreted into lumen; HCO₃⁻ reabsorbed basolaterally
Acetazolamide blocks this → HCO₃⁻ lost in urine → hyperchloremic normal anion gap metabolic acidosis

2. THIN DESCENDING LOOP OF HENLE

Key Facts

Permeable to H₂O, impermeable to Na⁺
Passively reabsorbs water via medullary hypertonicity
Concentrating segment — tubular fluid becomes hypertonic as it descends
No drug targets here

3. THICK ASCENDING LIMB (TAL) OF LOOP OF HENLE

Key Facts

Impermeable to H₂O — this is critical for the countercurrent multiplier
Reabsorbs Na⁺, K⁺, 2Cl⁻ via the NKCC2 cotransporter (apical)
Reabsorbs Mg²⁺ and Ca²⁺ paracellularly (driven by the K⁺ back-leak generating a lumen-positive potential)
Makes urine less concentrated as it ascends (diluting segment)
Reabsorbs 10–20% of Na⁺

Drug Target

Agent	Action	Effect
Loop diuretics (furosemide, bumetanide)	Block NKCC2	↓ Na⁺, K⁺, Cl⁻, Mg²⁺, Ca²⁺ reabsorption; loss of urinary concentrating ability

High-yield: Loop diuretics cause hypocalcemia (block paracellular Ca²⁺ reabsorption). Thiazides cause hypercalcemia.

4. EARLY DISTAL CONVOLUTED TUBULE (DCT)

Key Facts

Reabsorbs Na⁺ and Cl⁻ via NCC cotransporter
Impermeable to H₂O — makes urine fully dilute (hypotonic)
Reabsorbs 5–10% of Na⁺
PTH → ↑ Ca²⁺/Na⁺ exchange → ↑ Ca²⁺ reabsorption
Reabsorbs Mg²⁺

Drug Target

Agent	Action	Effect
Thiazide diuretics (HCTZ)	Block NCC cotransporter	↓ Na⁺/Cl⁻ reabsorption; ↑ Ca²⁺ reabsorption (used in hypercalciuria/kidney stones)

Key contrast: Loop diuretics → ↓ Ca²⁺; Thiazides → ↑ Ca²⁺

5. COLLECTING TUBULE / COLLECTING DUCT

Two Cell Types:

Principal Cells

Reabsorb Na⁺ via ENaC (epithelial Na⁺ channel, apical)
Secrete K⁺ via ROMK channel
Aldosterone → acts on mineralocorticoid receptor → new mRNA → new protein synthesis → ↑ ENaC, ↑ Na⁺/K⁺-ATPase → lumen negativity → ↑ K⁺ secretion
ADH (vasopressin) → acts on V₂ receptor → inserts aquaporin-2 channels on apical membrane → ↑ H₂O reabsorption

Alpha-Intercalated Cells (α-IC)

Secrete H⁺ via H⁺-ATPase (apical)
Reabsorb HCO₃⁻ via HCO₃⁻/Cl⁻ exchanger (basolateral)
Activated by acidosis

Beta-Intercalated Cells (β-IC)

Secrete HCO₃⁻ into lumen
Reabsorb Cl⁻
Activated by alkalosis

Drug Targets

Agent	Action	Effect
Spironolactone / Eplerenone	Aldosterone receptor antagonist	↓ Na⁺ reabsorption, ↓ K⁺ secretion → K⁺-sparing diuretic
Amiloride / Triamterene	Block ENaC directly	↓ Na⁺ reabsorption, ↓ K⁺ secretion → K⁺-sparing diuretic

Sodium Reabsorption Summary by Segment

Segment	% Na⁺ Reabsorbed
PCT	65–80%
Thin descending LOH	~0%
Thick ascending LOH	10–20%
Early DCT	5–10%
Collecting duct	3–5%

HIGH-YIELD USMLE-STYLE MCQs

Q1. A patient with heart failure is started on furosemide. Which of the following electrolyte abnormalities is MOST expected?

A) Hyperkalemia, hypercalcemia
B) Hypokalemia, hypocalcemia
C) Hypokalemia, hypercalcemia
D) Hyperkalemia, hypocalcemia
E) Hypomagnesemia, hypernatremia

✅ Answer: B — Hypokalemia, hypocalcemia Loop diuretics block NKCC2 in the TAL, reducing the lumen-positive potential that drives paracellular Ca²⁺ and Mg²⁺ reabsorption. K⁺ is lost because less Na⁺ reaches the collecting duct and loop blockade reduces K⁺ recycling.

Q2. A 55-year-old man with recurrent calcium oxalate kidney stones is treated with a drug that increases Ca²⁺ reabsorption in the DCT. This drug's primary mechanism is:

A) Blocking Na⁺/K⁺/2Cl⁻ cotransporter
B) Inhibiting carbonic anhydrase
C) Blocking Na⁺/Cl⁻ cotransporter
D) Blocking ENaC
E) Inhibiting aldosterone receptor

✅ Answer: C — Blocking NCC (Na⁺/Cl⁻ cotransporter) Thiazide diuretics block NCC in the DCT. The resulting intracellular Na⁺ depletion upregulates basolateral Na⁺/Ca²⁺ exchange, pulling more Ca²⁺ into the cell → ↓ urinary Ca²⁺ → used for hypercalciuria.

Q3. A patient with Conn syndrome (primary hyperaldosteronism) will most likely have which acid-base disturbance?

A) Metabolic acidosis, hyperkalemia
B) Metabolic alkalosis, hypokalemia
C) Respiratory alkalosis, hyponatremia
D) Metabolic acidosis, hyponatremia
E) Respiratory acidosis, hyperkalemia

✅ Answer: B — Metabolic alkalosis, hypokalemia Excess aldosterone → ↑ ENaC activity → lumen negativity → ↑ K⁺ secretion (hypokalemia) and ↑ H⁺ secretion by α-intercalated cells (metabolic alkalosis).

Q4. Which nephron segment is PRIMARILY responsible for generating a hypertonic medullary interstitium?

A) Proximal convoluted tubule
B) Thin descending loop of Henle
C) Thick ascending limb of loop of Henle
D) Early DCT
E) Collecting duct

✅ Answer: C — Thick ascending limb The TAL pumps Na⁺/K⁺/2Cl⁻ into the interstitium WITHOUT allowing water to follow (impermeable to H₂O), building up the hypertonic medullary gradient essential for urinary concentration.

Q5. A patient is given acetazolamide for glaucoma. Which of the following best describes the expected acid-base change?

A) Metabolic alkalosis
B) Respiratory acidosis
C) Hyperchloremic normal anion gap metabolic acidosis
D) High anion gap metabolic acidosis
E) Respiratory alkalosis

✅ Answer: C — Hyperchloremic normal anion gap metabolic acidosis Acetazolamide blocks CA in the PCT → less H⁺ secreted → less HCO₃⁻ reabsorbed → HCO₃⁻ lost in urine. Cl⁻ is reabsorbed in its place → hyperchloremia. Anion gap stays normal.

Q6. ADH (vasopressin) increases water permeability of the collecting duct by:

A) Opening ROMK channels
B) Activating ENaC
C) Inserting aquaporin-2 into the apical membrane via V₂ receptor
D) Stimulating aldosterone release
E) Inhibiting Na⁺/K⁺-ATPase

✅ Answer: C — Aquaporin-2 insertion via V₂ receptor ADH binds V₂ receptor (Gs-coupled) → ↑ cAMP → PKA phosphorylates AQP2 vesicles → fusion with apical membrane → ↑ water permeability. This is the target of nephrogenic DI (V₂ receptor mutations) and lithium toxicity.

Q7. PTH acts on the PCT to:

A) Increase phosphate reabsorption
B) Decrease calcium reabsorption
C) Inhibit Na⁺/PO₄³⁻ cotransport → increase phosphaturia
D) Stimulate HCO₃⁻ secretion
E) Increase glucose reabsorption

✅ Answer: C — Inhibit Na⁺/PO₄³⁻ cotransport → phosphaturia PTH inhibits the Na⁺-phosphate cotransporter (NaPi-2a/2c) in the PCT brush border → ↑ PO₄³⁻ in urine. In the DCT, PTH stimulates Ca²⁺ reabsorption. Net: ↑ Ca²⁺, ↓ PO₄³⁻.

Quick Memory Table — Diuretics & Site of Action

Diuretic	Site	Transporter Blocked	Key Side Effect
Acetazolamide	PCT	Carbonic anhydrase	Metabolic acidosis
Furosemide	TAL (LOH)	NKCC2	Hypokalemia, Hypocalcemia, Ototoxicity
Hydrochlorothiazide	DCT	NCC	Hypokalemia, Hypercalcemia, hyperglycemia
Amiloride/Triamterene	Collecting duct	ENaC	Hyperkalemia
Spironolactone/Eplerenone	Collecting duct	Aldosterone receptor	Hyperkalemia, gynecomastia (spiro)

Mnemonic for PCT reabsorption: "GHAKP" — Glucose, HCO₃⁻, Amino acids, K⁺, Phosphate — all maximally reabsorbed here.

Mnemonic for TAL: "TAL has No Water" (impermeable to H₂O) and "FRUSEMIDE Fuels the Loop"

This is a shared conversation. Sign in to Orris to start your own chat.